Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2017-04-06
2020-09-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RYGB surgery
Obese patients eligible for laparoscopic Roux-en-Y gastric bypass (RYGB) surgery.
Endoscopic Linear Cutter Stapler and reloads
Endoscopic Linear Cutter Stapler and reloads
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic Linear Cutter Stapler and reloads
Endoscopic Linear Cutter Stapler and reloads
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must sign and date the informed consent form prior to the index-procedure.
* Patient has a BMI ≥ 35 kg/m with one or more related co-morbidity.
* Patient has a BMI ≥ 40 kg/m.
Exclusion Criteria
* History of bariatric surgery.
* Patient is known to be, or suspected of being unable to comply with the study protocol or proposed follow-up visits.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duomed
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hans Verhelst, Dr.
Role: PRINCIPAL_INVESTIGATOR
ZOL, Genk
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ST-01
Identifier Type: -
Identifier Source: org_study_id